⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBLG News
FibroBiologics, Inc. Common Stock
Form 8-K
sec.gov
FBLG
FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update
globenewswire.com
FBLG
FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026
globenewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Compliant with All Nasdaq Listing Requirements
globenewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
globenewswire.com
FBLG
Form 8-K/A
sec.gov
FBLG
Form 8-K
sec.gov
FBLG
Form 8-K
sec.gov
FBLG